Photo by Daniel H. Tong on Unsplash
News /

Evidence-Based Practice for Termination of Pregnancy with Mifepristone and Misoprostol in Kazakhstan

Almaty, Kazakhstan

In collaboration with the Kazakhstan Association on Sexual and Reproductive Health and the Kazakhstan-Russian Medical University, Gynuity Health Projects organized a conference on current evidence-based practices in medical abortion. One hundred twenty participants, including faculty members, students, representatives from local NGO, and abortion providers, attended the conference. The participants heard presentations on current family planning trends in Kazakhstan, use of contraceptives after abortion, and evidence-based practice for medical abortion in the first and second trimesters. During this conference, Gynuity staff also disseminated the results from a recently completed study on an outpatient medical abortion up to 70 days LMP, which offered women the option to take mifepristone and misoprostol at home. At the conclusion of the seminar, participants highlighted the importance of updating current national guidelines on medical abortion to incorporate evidence-based practice and increase access to this method.